Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Linker-Driven Sampling of PROTAC-Induced Ternary Complexes.

Journal of medicinal chemistry·2026
Same author

Exploring Secondary Structure Predictions for RNA-Targeted Drug Discovery: Power and Challenges.

Journal of chemical information and modeling·2026
Same author

PROTAC-Splitter: a machine learning framework for automated identification of PROTAC substructures.

Journal of cheminformatics·2026
Same author

Correction: Enhanced Thompson sampling by roulette wheel selection for screening ultralarge combinatorial libraries.

Journal of cheminformatics·2025
Same author

Enhanced Thompson sampling by roulette wheel selection for screening ultralarge combinatorial libraries.

Journal of cheminformatics·2025
Same author

Emergence of learning and quality - using scientific social media facilitating a complex adaptive space in healthcare.

Journal of health organization and management·2025

Related Experiment Video

Updated: May 22, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

Exploiting structural information in patent specifications for key compound prediction.

Christian Tyrchan1, Jonas Boström, Fabrizio Giordanetto

  • 1AstraZeneca R&D, CVGI iMed, Pepparedsleden 1, S-431 83 Mölndal, Sweden. christian.tyrchan@astrazeneca.com

Journal of Chemical Information and Modeling
|May 30, 2012
PubMed
Summary
This summary is machine-generated.

Automated cheminformatics methods can predict key compounds in patent literature, aiding drug discovery. Cluster seed analysis achieved 54% accuracy, while novel frequency of R-groups (FOG) and maximum common substructure (MCS) methods offer visualization advantages.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Related Experiment Videos

Last Updated: May 22, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Area of Science:

  • Medicinal Chemistry
  • Cheminformatics
  • Intellectual Property Analysis

Background:

  • Patent analysis is crucial for drug discovery, including prior art assessment, novelty checking, and identifying new chemical exploration starting points.
  • Traditional manual searching of patent specifications is time-consuming and can be complemented by cheminformatics methods.
  • Automated methods can extract structural information from patents to identify key compounds, potentially replacing or enhancing manual approaches.

Purpose of the Study:

  • To describe and compare three distinct cheminformatics methods for the automatic prediction of key compounds in patent specifications using only structural information.
  • To evaluate the prediction accuracy of these methods on a dataset of drug patents.
  • To assess the advantages of novel methods, such as visualization of structural features.

Main Methods:

  • Comparison of three automated prediction methods: cluster seed analysis, frequency of R-groups (FOG), and maximum common substructure (MCS) similarity.
  • Utilizing structural information extracted from patent documents.
  • Evaluating prediction accuracy based on correctly identified key compounds (drugs) from their corresponding patents.

Main Results:

  • Cluster seed analysis demonstrated superior prediction accuracy, correctly identifying 54% (26 out of 48) of drugs from their patents.
  • The FOG and MCS methods, while showing lower accuracy in this dataset, offer significant advantages in visualizing relevant structural features.
  • Manual selection of scaffolds in the FOG method can enhance its results.

Conclusions:

  • Automated cheminformatics methods, particularly cluster seed analysis, are effective for predicting key compounds in patent specifications.
  • FOG and MCS methods provide valuable structural insights, complementing prediction accuracy with interpretability.
  • The FOG method, especially with scaffold selection, shows promise for drug design, as demonstrated by its application in developing AXL kinase inhibitors.